| Nizar Habal, MD | |
|
2223 Hemby Lane, Greenville, NC 27834-2868 | |
| (252) 413-0036 | |
| (252) 413-0038 |
| Full Name | Nizar Habal |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 31 Years |
| Location | 2223 Hemby Lane, Greenville, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215932223 | NPI | - | NPPES |
| 126T0 | Other | NC | BCBS |
| 89126T0 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 200000442 (North Carolina) | Secondary |
| 2086X0206X | Surgery - Surgical Oncology | 200000442 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vidant Medical Center | Greenville, NC | Hospital |
| Vidant Chowan Hospital | Edenton, NC | Hospital |
| Entity Name | Carolina Breast & Oncologic Surgery Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134190630 PECOS PAC ID: 8123055951 Enrollment ID: O20080326000625 |
News Archive
Alexion Pharmaceuticals, Inc. today announced that the European Commission has granted an orphan drug designation (ODD) to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of graft rejection following solid organ transplantation. Graft rejection can cause severe injury to the transplanted organ and is a significant barrier to successful transplantation.
Inovio Pharmaceuticals, Inc., which is advancing synthetic vaccines to fight cancers and infectious diseases, announced today that a single intradermal (ID) electroporation boost of its SynCon avian influenza vaccine generated HAI titers against six different, unmatched strains of H5N1 - a distinct new clinical achievement on the global research community's path to develop universal influenza vaccines.
According to British research, people with a below average mental agility are prone to heart attacks.
A new survey from Pew Research Center has found that nearly half of the surveyed Americans believe that in the coming 50 years, nearly all genetic birth defects could be eliminated due to advances in gene editing.
Uroplasty, Inc. has announced that it has received an approvable letter from the U.S. Food and Drug Administration (FDA) relating to its pre-market approval (PMA) application for Macroplastique Implants for the treatment of female stress urinary incontinence (SUI).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nizar Habal, MD 2223 Hemby Lane, Greenville, NC 27834-2868 Ph: (252) 413-0036 | Nizar Habal, MD 2223 Hemby Lane, Greenville, NC 27834-2868 Ph: (252) 413-0036 |
News Archive
Alexion Pharmaceuticals, Inc. today announced that the European Commission has granted an orphan drug designation (ODD) to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of graft rejection following solid organ transplantation. Graft rejection can cause severe injury to the transplanted organ and is a significant barrier to successful transplantation.
Inovio Pharmaceuticals, Inc., which is advancing synthetic vaccines to fight cancers and infectious diseases, announced today that a single intradermal (ID) electroporation boost of its SynCon avian influenza vaccine generated HAI titers against six different, unmatched strains of H5N1 - a distinct new clinical achievement on the global research community's path to develop universal influenza vaccines.
According to British research, people with a below average mental agility are prone to heart attacks.
A new survey from Pew Research Center has found that nearly half of the surveyed Americans believe that in the coming 50 years, nearly all genetic birth defects could be eliminated due to advances in gene editing.
Uroplasty, Inc. has announced that it has received an approvable letter from the U.S. Food and Drug Administration (FDA) relating to its pre-market approval (PMA) application for Macroplastique Implants for the treatment of female stress urinary incontinence (SUI).
› Verified 6 days ago
Dr. Michael W.a. Chu, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 600 Moye Blvd, Leo Jenkins Cancer Center, Greenville, NC 27834 Phone: 252-744-4822 Fax: 252-744-9004 | |
Dr. Yifan Guo, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 517 Moye Blvd, Ecu Physicians Plastic Surgery, Greenville, NC 27834 Phone: 252-744-5291 Fax: 252-744-5778 | |
Shannon Wright Longshore, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 517 Moye Blvd, Greenville, NC 27834 Phone: 252-744-2832 Fax: 252-744-3457 | |
Dr. Frances Chinenye Okolo, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 517 Moye Blvd, Greenville, NC 27834 Phone: 252-744-2832 Fax: 252-744-3457 | |
Timothy W Mcguire, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1850 W Arlington Blvd, Greenville, NC 27834 Phone: 252-413-6735 Fax: 252-752-2019 | |
David Anthony Rodeberg, MD Surgery Medicare: Medicare Enrolled Practice Location: 517 Moye Blvd, Greenville, NC 27834 Phone: 252-744-2832 Fax: 252-744-3457 | |
Dr. Simon C Moten, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 600 Moye Blvd, Life Science Building-cardiothoracic Outpatient Clin., Greenville, NC 27834 Phone: 252-744-4822 Fax: 252-744-5192 |